BR112014015444A2 - composição, preparação e uso de materiais de membrana de quitosana densa - Google Patents

composição, preparação e uso de materiais de membrana de quitosana densa

Info

Publication number
BR112014015444A2
BR112014015444A2 BR112014015444A BR112014015444A BR112014015444A2 BR 112014015444 A2 BR112014015444 A2 BR 112014015444A2 BR 112014015444 A BR112014015444 A BR 112014015444A BR 112014015444 A BR112014015444 A BR 112014015444A BR 112014015444 A2 BR112014015444 A2 BR 112014015444A2
Authority
BR
Brazil
Prior art keywords
composition
dense
chitosan
dense chitosan
exceptionally
Prior art date
Application number
BR112014015444A
Other languages
English (en)
Inventor
Ellis April
A DeCarlo Arthur
Belousova Maria
p dooley Thomas
Original Assignee
Agenta Biotechnologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agenta Biotechnologies Inc filed Critical Agenta Biotechnologies Inc
Publication of BR112014015444A2 publication Critical patent/BR112014015444A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
    • C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
    • C08J3/075—Macromolecular gels
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2305/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00
    • C08J2305/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

abstract a composition of exceptionally dense chitosan and a novel method for producing the dense chitosan structure have been described. the novel production method employs coincident compression and vacuum on a neutralized chitosan polymer that results in an exceptionally dense chitosan film or membrane material. the dense chitosan film or membrane composition possesses multiple physical and clinically appealing qualities for a variety of medical applications on or in animals, mammals, or humans. _______________________ tradução do resumo resumo patente de invenção: "composição, preparação e uso de materiais de membrana de quitosana densa". uma composição de quitosana excepcionalmente densa e um método novo para produzir a estrutura de quitosana densa foram descritos. o método de produção novo emprega compressão e vácuo coincidentes em um polímero de quitosana neutralizado que resulta em um material de filme ou membrana de quitosana excepcionalmente densa. a composição de filme ou membrana de quitosana densa pos-sui múltiplas qualidades fisicamente e clinicamente de apelo para uma variedade de aplicações médicas em ou dentro de animais, mamíferos ou humanos.
BR112014015444A 2011-12-22 2012-12-19 composição, preparação e uso de materiais de membrana de quitosana densa BR112014015444A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161579003P 2011-12-22 2011-12-22
PCT/US2012/070617 WO2013096448A1 (en) 2011-12-22 2012-12-19 Composition, preparation, and use of dense chitosan membrane materials

Publications (1)

Publication Number Publication Date
BR112014015444A2 true BR112014015444A2 (pt) 2017-07-04

Family

ID=48669446

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014015444A BR112014015444A2 (pt) 2011-12-22 2012-12-19 composição, preparação e uso de materiais de membrana de quitosana densa

Country Status (7)

Country Link
EP (1) EP2793908A4 (pt)
JP (1) JP2015511214A (pt)
KR (1) KR20140122231A (pt)
CN (1) CN104144692A (pt)
BR (1) BR112014015444A2 (pt)
IL (1) IL233290A0 (pt)
WO (1) WO2013096448A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103893204B (zh) * 2014-04-03 2016-05-11 石家庄亿生堂医用品有限公司 一种壳聚糖盐酸盐钙止血粉的制备方法
WO2017099261A1 (ko) * 2015-12-07 2017-06-15 주식회사 글로원 염침출 및 침지침강법을 이용한 스캐폴더 제조방법 및 그 스캐폴더
WO2017122216A1 (en) * 2016-01-14 2017-07-20 Amnivor Medicare Private Limited A process for extraction of collagen from fish scale and polyelectrolyte based bioactive super-absorbent materials
CN109627463B (zh) * 2016-06-22 2022-04-01 深圳普洛美康材料有限公司 水凝胶与蛋白质药物
EP3534975B1 (en) * 2016-11-04 2022-04-20 Axio Biosolutions Pvt. Ltd Mucoadhesive preparations, methods and applications thereof
WO2019051750A1 (zh) * 2017-09-14 2019-03-21 谭玲 一种聚乙二醇改性壳聚糖膜的制备方法
JP6933394B2 (ja) * 2018-09-06 2021-09-08 マリン エッセンス バイオサイエンシズ コーポレーション オブ ユーエスエーＭａｒｉｎｅ Ｅｓｓｅｎｃｅ Ｂｉｏｓｃｉｅｎｃｅｓ Ｃｏｒｐｏｒａｔｉｏｎ ｏｆ ＵＳＡ 組織再生誘導のためのバイオマテリアルデバイスおよび局所用組成物
KR102205564B1 (ko) * 2019-03-08 2021-01-22 주식회사 제론바이오 Pdrn이 캡슐화된 키토산 나노 입자가 포함된 키토산 나노필름 및 이의 제조 방법
CN111234289B (zh) * 2020-02-11 2022-04-01 南通大学 一种防粘连聚甲醛结扎止血夹及其制备方法与应用
KR102256257B1 (ko) * 2020-04-21 2021-05-26 한국화학연구원 키랄상의 질소-도핑된 네마틱 탄소-쉬스 나노섬유, 이의 제조방법, 및 이의 용도
CN114306714B (zh) * 2021-12-31 2022-08-02 安徽科门生物科技有限公司 一种制备用于皮肤再生修复的干细胞复合生物材料的方法
CN115252879A (zh) * 2022-07-13 2022-11-01 肖地生 一种壳聚糖止血材料的制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020131933A1 (en) * 1996-01-16 2002-09-19 Yves Delmotte Biopolymer membrane and methods for its preparation
US6271278B1 (en) * 1997-05-13 2001-08-07 Purdue Research Foundation Hydrogel composites and superporous hydrogel composites having fast swelling, high mechanical strength, and superabsorbent properties
US6740752B2 (en) * 2000-05-12 2004-05-25 The Procter & Gamble Company Process for preparing chitosan particles
US7371403B2 (en) * 2002-06-14 2008-05-13 Providence Health System-Oregon Wound dressing and method for controlling severe, life-threatening bleeding
US7536962B2 (en) * 2005-04-19 2009-05-26 Kamterter Ii, L.L.C. Systems for the control and use of fluids and particles

Also Published As

Publication number Publication date
JP2015511214A (ja) 2015-04-16
KR20140122231A (ko) 2014-10-17
IL233290A0 (en) 2014-08-31
EP2793908A1 (en) 2014-10-29
EP2793908A4 (en) 2015-08-19
CN104144692A (zh) 2014-11-12
WO2013096448A1 (en) 2013-06-27

Similar Documents

Publication Publication Date Title
BR112014015444A2 (pt) composição, preparação e uso de materiais de membrana de quitosana densa
BR112014006842A2 (pt) construção de lista de imagens de referência para codificação de vídeo
CL2010001582A1 (es) Polvo de polimeros redispersable en agua,que contiene por lo menos un latex natural modificado; proceso de preparacion; uso como aditivo en composiciones de materiales de construcion; composiciones; proceso para hidrofobizar y/o flexibilizar composiciones curadas de materiales de construccion.
BRPI1011220A2 (pt) composição farmacêutica, métodos para tratar uma doença ou distúrbio, para administração respiratória de dois ou mais agentes ativos, para administração respiratória de uma combinação de agentes ativos, e, para preparar uma composição adequada.
ECSP10010548A (es) Composiciones y metodos de preparacion y uso de las mismas
BR112015000320A2 (pt) composições farmacêuticas dissuasivas de abuso, de liberação prolongada
CL2012001950A1 (es) Uso de una cepa bacteriana probiotico en la fabricacion de un medicamento o composicion nutricional en humanos o animales para alterar los patrones del sueño
BR112012003468A2 (pt) processo para a produção de polímeros de polibifenilsulfona, polímero de polibifenilsulfona, composição termoplástica para moldagem, corpo moldado, fibra, filme, membrana ou espuma, e, uso das composições termoplásticas para moldagem ou dos polímeros de polibifenilsulfona.
BR112012022800A2 (pt) composição imunogênica ou vacina, cepa bacteriana gram-negativa geneticamente engenheirada, métodos para o tratamento ou prevenção de infecção ou doença, para produzir uma composição imunogênica ou uma vacina, e para preparar uma imunoglobulina, preparação da imunoglobulina, e, preparação farmacêutica
BRPI0508403A (pt) produtos de pelìcula tendo propriedades de desintegração controlada
BR112015023366A2 (pt) resina de poliéter, composição de revestimento, e método de revestimento de um substrato
BR112012022797A2 (pt) composição farmacêutica resistente a álcool, e, método para tratar uma doença com uma formulação de agente ativo resistente a álcool
FR2964565B1 (fr) Composition cosmetique comprenant un polymere fixant et un agent antipelliculaire
RS54014B1 (en) COMBINATION FOR TREATMENT OF MUCOSITIS CAUSED BY RADIATION OR CHEMOTHERAPY
MX362168B (es) Composiciones estables que comprenden tiabendazol y fungicidas que contienen yodo.
BR112014010758A2 (pt) composições de resina reciclada e dispositivos médicos descartáveis produzidos com base em tais composições
BR112013000747A8 (pt) "metodo para proteger uma superficie de polimero contra incrustação, superficie de polimero. composto de polimero que tem propriedades anti-incrustação e compósito de polimero que tem a propriedade de superficie funcionalizada"
CL2008000955A1 (es) Proceso para la preparacion de hebras de polimero a partir de homopolimeros o copolimeros de peso molecular ultra elevado y con una distribucion de peso molecular bimodal o multimodal; hebras de polimero; y uso de hebras de polimero.
BR112014013641A2 (pt) composição de polímero curável, e, compósito
BR112013010829B8 (pt) Composição farmacêutica intravenosa para proporcionar alívio da dor e/ou da inflamação
BR112012017300A2 (pt) processo de para preparação de uma biomassa compreendendo plantaricina e usos da mesma no campo médico
ATE547110T1 (de) Verwendung von zellen aus fettgewebe zur herstellung eines antitumoralen medikaments
BR112016007487A2 (pt) composições compreendendo citrulina e leucina e seu uso no tratamento de diabetes e de síndrome meta-bólica
BR112016007322A2 (pt) composições compreendendo materiais de perfume compatíveis com polímero de poliamina
UA96390C2 (uk) Кровозамінник із функцією переносу кисню, фармацевтична композиція (варіанти)

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]